Fragility of Randomized Controlled Trials for Fluid Resuscitation in Acute Pancreatitis
Digestive Diseases and Sciences · 2026
DOI: 10.1007/s10620-026-10099-1 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Anshuman Elhence und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGI), Lucknow, India. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Pancreatitis, Fluid Therapy, Treatment Outcome. Die Arbeit nennt 26 Literaturangaben.
Themen: Reanimation
Abstract (Originalsprache)
BACKGROUND AND AIM: Majority trials evaluating fluid resuscitation in acute pancreatitis (AP) are small and contradictory. Fragility score is the minimum number of participants in a randomized controlled trial (RCT) whose outcome would have to change from non-event to event to overturn the results. We planned to evaluate the fragility of RCTs evaluating fluid resuscitation in AP. METHODS: After a systematic review of literature (CRD420261321080), fragility index (FI), reverse fragility index (RFI), and fragility quotient (FQ) were calculated. The results were labeled as fragile if FI ≤ 3, RFI ≤ 5, or FQ ≤ 0.10. Further sub-group comparisons of fragility scores were conducted as a secondary outcome. RESULTS: Among these 13 included studies, 26 primary or key secondary outcomes were evaluated. The mean FI was 2.83 (2.08) among the studies with significant results. The mean RFI was 5.35 (2.59) among the studies with non-significant results. The median FQ was 0.023 (interquartile range 0.02 to 0.078). The FI was ≤ 3 for 9 (75%) outcomes with significant results. The RFI was ≤ 5 for 8 (57.1%) with non-significant results, 23 (88.5%) of the outcomes were fragile as defined by FQ ≤ 0.10, and 25 (96.2%) of the results were fragile by any definition. The mean FI 3 (2) was lower as compared to mean RFI 5.35 (2.59), p = 0.01. CONCLUSION: Majority of the studies evaluating fluid resuscitation in AP are fragile. Larger sample size or alternate designs should be considered in future trials evaluating fluid resuscitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGI), Lucknow, India.
- Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGI), Lucknow, India.
- Department of Gastroenterology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences (SGPGI), Lucknow, India. praveer_rai@yahoo.com.
ORCID-Profile: Praveer Rai
Zitieren
APA
Elhence, A., Patel, A., Misra, D. P., & Rai, P. (2026). Fragility of Randomized Controlled Trials for Fluid Resuscitation in Acute Pancreatitis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10099-1
Vancouver
Elhence A, Patel A, Misra DP, Rai P. Fragility of Randomized Controlled Trials for Fluid Resuscitation in Acute Pancreatitis. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10099-1
BibTeX
@article{Elhence2026,
author = {Elhence, Anshuman and Patel, Abhishek and Misra, Durga Prasanna and Rai, Praveer},
title = {Fragility of Randomized Controlled Trials for Fluid Resuscitation in Acute Pancreatitis},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-10099-1}
}
EUVIMED